NASDAQ:ELVN
Enlivex Therapeutics Ltd.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.enliventherapeutics.comipo date
Mar 12, 2020
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus